Because almost all miR-29 transgenics showed expanded CD5+CD19+IgM+ Bcell populations, but only 20% develop frank leukemia we concluded that miR-29 transgenics develop a disease similar to indolent CLL [15]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.